Niagen Bioscience, Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
NAGE Nasdaq 2840 www.niagenbioscience.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Niagen Bioscience, Inc.

Niagen Bioscience (NAGE): Evaluating Valuation After Long COVID Study and Tru Niagen Beauty Launch - Nov 27th, 2025 1:19 am
Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside) - Nov 13th, 2025 6:32 am
Shareholders Can Be Confident That Niagen Bioscience's (NASDAQ:NAGE) Earnings Are High Quality - Nov 13th, 2025 4:57 am
Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID - Nov 12th, 2025 5:52 pm
3 Growth Companies With High Insider Ownership And Up To 26% Revenue Growth - Nov 11th, 2025 10:35 am
Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Nov 7th, 2025 4:29 am
Niagen Bioscience Announces $10 Million Share Repurchase Program - Nov 6th, 2025 6:07 am
Strong Q3 Results and Raised Guidance Might Change the Case for Investing in Niagen Bioscience (NAGE) - Nov 5th, 2025 3:11 pm
3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value - Nov 5th, 2025 10:38 am
3 Stocks Estimated To Be Up To 46.5% Below Intrinsic Value - Nov 5th, 2025 4:38 am
Niagen Bioscience Inc (NAGE) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Nov 4th, 2025 10:03 pm
Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates - Nov 4th, 2025 4:00 pm
Niagen Bioscience: Q3 Earnings Snapshot - Nov 4th, 2025 2:58 pm
Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook - Nov 4th, 2025 2:02 pm
Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline - Oct 29th, 2025 8:00 am
Niagen Bioscience (NAGE) Reports Next Week: What to Expect - Oct 28th, 2025 8:00 am
Niagen Bioscience to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - Oct 21st, 2025 6:32 am
National Advertising Division Finds Certain Reus Cata-Kor NAD+ Claims Supported; Recommends Others Be Modified or Discontinued - Oct 13th, 2025 9:00 am
3 Growth Companies With Insider Ownership Up To 29% - Oct 13th, 2025 5:35 am
Owning 37% shares,institutional owners seem interested in Niagen Bioscience, Inc. (NASDAQ:NAGE), - Oct 9th, 2025 11:44 am